Showing results (71-80 of 332) with videos related to
Sort By:
Pageof 34
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemiaRégis Peffault de Latour, Claudio G Brunstein, Raphael Porcher, et al.Bulletin Du Cancer|November 16, 2016
[Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)]Aurélie Jaspers, Salaheddine Bouhya, Stéphanie Belaiche, et al.Annals of Hematology|November 21, 2014
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationEolia Brissot, Xavier Cahu, Thierry Guillaume, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2014
Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adultsPierre Peterlin, Jacques Delaunay, Thierry Guillaume, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working PartyCharalampia Kyriakou, Ariane Boumendil, Herve Finel, et al.European Journal of Haematology|August 10, 2013
BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principlePatrice Chevallier, Caroline Bodet-Milin, Nelly Robillard, et al.Mycoses|April 22, 2017
Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016)Jessie Bourcier, Pierre-Marie Heudes, Florent Morio, et al.Transfusion|January 17, 2013
Characterization of various blood and graft sources: a prospective seriesPatrice Chevallier, Nelly Robillard, Marina Illiaquer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemiaPatrice Chevallier, Jacques Delaunay, Pascal Turlure, et al.Cancers|December 4, 2020
Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell TransplantationLéa Dubreuil, Bercelin Maniangou, Patrice Chevallier, et al.Pageof 34